Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Medipal Holdings Corp (7459:JPX), powered by AI.
Medipal Holdings Corp is currently trading at ¥2,770. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Medipal Holdings Corp on Alpha Lenz.
Medipal Holdings Corp's P/E ratio is 14.3.
“Medipal Holdings Corp trades at a P/E of 14.3 (undervalued) with modest ROE of 6.6%.”
Ask for details →Medipal Holdings Corp is a leading company in Japan's pharmaceutical distribution industry. As a comprehensive pharmaceutical wholesaler, its primary function is to ensure the efficient distribution and availability of drugs, medical devices, and healthcare-related products across Japan. Medipal Holdings Corp operates in the healthcare, animal health, and cosmetics sectors, serving as a crucial link between manufacturers and end consumers, such as hospitals, pharmacies, and clinics. The company is recognized for its advanced logistics and supply chain solutions, which are vital in maintaining the integrity and efficiency of pharmaceutical distribution. By maintaining a robust network and leveraging technological innovations, Medipal plays a significant role in the healthcare market, contributing to the accessibility and availability of essential medicines and healthcare products in Japan. Its operations are critical, especially in times of public health emergencies, ensuring that healthcare providers receive the necessary supplies without delay.
“Medipal Holdings Corp trades at a P/E of 14.3 (undervalued) with modest ROE of 6.6%.”
Ask for details →